CEFDOCLAV

This brand name is authorized in Nigeria.

Active ingredients

The drug CEFDOCLAV contains a combination of these active pharmaceutical ingredients (APIs):

1	Cefpodoxime UNII 2TB00A1Z7N - CEFPODOXIME PROXETIL
	Like other beta-lactam drugs, cefpodoxime exerts antibacterial activity by binding to and inhibiting the action of certain bacterial cell wall synthetic enzymes, namely the penicillin binding proteins.
	Read more about Cefpodoxime
2	Clavulanic acid UNII Q42OMW3AT8 - CLAVULANATE POTASSIUM
	Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin.
	Read more about Clavulanic acid

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100758	Tablet	CEFDOCLAV 325 TABLET TAB 200 mg; 125 mg 1 X 10	6 NF-PP-362126 CEFDOCLAV 325 TABLET Cefpodoxime and Clavulanate Potassium 325 mg Each film coated tablet contains: Cefpodoxime Proxetil USP equivalent to Cefpodoxime................... 200 mg Clavulanate Potassium USP Equivalent to Clavulanic Acid …………… 125 mg Excipients………………………………….q.s A4-100758 Drugs Imported Products 110 Prescription Only Medicine (POM) 9/13/2023 DE - STILL PHARMACY LTD , 1A, ATINUKE STREET, NULL NULL, ILASAMAJA ,LAGOS. ILASAMAJA LAGOS 7064946450 destillrejoice@gmail.com MAXMED LIFESCIENCES PVT LTF, Plot No-54 & 55, Sector-IIDC, SIDCUL, Rudrapur, Udhamsingh Nagar, Uttarakhand. India. , India	28/02/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD64		J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD64

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100758